ATE374781T1 - Derivate von genkwanin und sakuranetin, deren kosmetische und therapeutische verwendung, und verfahren zu deren herstellung - Google Patents

Derivate von genkwanin und sakuranetin, deren kosmetische und therapeutische verwendung, und verfahren zu deren herstellung

Info

Publication number
ATE374781T1
ATE374781T1 AT05736945T AT05736945T ATE374781T1 AT E374781 T1 ATE374781 T1 AT E374781T1 AT 05736945 T AT05736945 T AT 05736945T AT 05736945 T AT05736945 T AT 05736945T AT E374781 T1 ATE374781 T1 AT E374781T1
Authority
AT
Austria
Prior art keywords
genkwanin
sakuranetin
cosmetic
antiradical
skin
Prior art date
Application number
AT05736945T
Other languages
English (en)
Inventor
Michel Prost
Jacqueline Ragot
Pierre Tubery
Original Assignee
Michel Prost
Jacqueline Ragot
Pierre Tubery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michel Prost, Jacqueline Ragot, Pierre Tubery filed Critical Michel Prost
Application granted granted Critical
Publication of ATE374781T1 publication Critical patent/ATE374781T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05736945T 2004-03-11 2005-03-11 Derivate von genkwanin und sakuranetin, deren kosmetische und therapeutische verwendung, und verfahren zu deren herstellung ATE374781T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0402554A FR2867476B1 (fr) 2004-03-11 2004-03-11 Derives de genkwanine et sakuranetine, utilisation cosmetique et therapeutique, et procede de preparation

Publications (1)

Publication Number Publication Date
ATE374781T1 true ATE374781T1 (de) 2007-10-15

Family

ID=34896465

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05736945T ATE374781T1 (de) 2004-03-11 2005-03-11 Derivate von genkwanin und sakuranetin, deren kosmetische und therapeutische verwendung, und verfahren zu deren herstellung

Country Status (8)

Country Link
US (1) US7935672B2 (de)
EP (1) EP1730159B1 (de)
CN (1) CN1950390A (de)
AT (1) ATE374781T1 (de)
CA (1) CA2559377C (de)
DE (1) DE602005002734D1 (de)
FR (1) FR2867476B1 (de)
WO (1) WO2005087786A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5187802B2 (ja) * 2006-01-18 2013-04-24 公益財団法人名古屋産業科学研究所 緩下剤及びこれを含む食品
JP2008105995A (ja) * 2006-10-25 2008-05-08 Kao Corp 皮膚外用剤
FR2916977A1 (fr) * 2007-06-06 2008-12-12 Engelhard Lyon Sa STIMULATION DE LA SYNTHESE DES RECPTEURS MCR1, MCR2 ET µ OPIOIDE.
CN101456886B (zh) * 2007-12-10 2013-04-10 上海国源生物技术有限公司 瑞香樱草糖-芫花黄素和瑞香属植物的用途
EP2202237A1 (de) * 2008-12-23 2010-06-30 Libragen Wasserlösliche [6)-O-alpha-D-Glcp-(1->]n-6-O-beta-D-Glcp-(1->-Phenol-Derivate mit Dermokosmetik-, Ernährungs- und Therapieanwendungen und Zusammensetzungen mit den wasserlöslichen Verbindungen
KR102008813B1 (ko) * 2013-08-14 2019-08-08 주식회사 엘지생활건강 피부 재생, 주름개선, 항산화, 항염증 및 피부 미백용 조성물
WO2017121855A1 (en) * 2016-01-15 2017-07-20 Universität Hamburg Flavonoide-type compounds bearing an o-rhamnosyl residue
EP3666250A1 (de) 2018-12-10 2020-06-17 ETH Zurich Kosmetische zubereitungen mit daphne-extrakten
CN114656437B (zh) * 2022-04-14 2023-08-08 中国海洋大学 一种具有urat1抑制活性的芫花素及其制备方法和应用
CN118995499B (zh) * 2024-08-19 2025-07-18 江苏知美美妆集团有限公司 一种樱花发酵产物及其制备方法、组合物和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985005031A1 (en) * 1984-05-09 1985-11-21 The Australian National University A method for the modulation of the immune response
FR2597751B1 (fr) * 1986-04-24 1990-10-05 Ragot Jacqueline Effet de synergie entre deux molecules d'origine vegetale : senegenine et 5-o-b-d-primeverosyl genkwanine utilisable dans le traitement de maladies liees a des desequilibres immunitaires
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
ITRM20010600A1 (it) * 2001-10-04 2003-04-04 Brane Tech S R L Composti flavonoidici capaci di modificare lo stato fisico e/o dinamico di membrane biologiche e di stimolare la sintesi endogena di protein

Also Published As

Publication number Publication date
CA2559377C (fr) 2013-01-08
US7935672B2 (en) 2011-05-03
DE602005002734D1 (de) 2007-11-15
CN1950390A (zh) 2007-04-18
US20070299018A1 (en) 2007-12-27
FR2867476A1 (fr) 2005-09-16
EP1730159A1 (de) 2006-12-13
EP1730159B1 (de) 2007-10-03
FR2867476B1 (fr) 2006-05-26
WO2005087786A1 (fr) 2005-09-22
CA2559377A1 (fr) 2005-09-22

Similar Documents

Publication Publication Date Title
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
PT671161E (pt) Ectoina e derivados de ectoina como distribuidor de humidade em produtos cosmeticos
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE344669T1 (de) 4-fluoro-n-indan-2-yl benzamid und seine verwendung als arzneimittel
DE69912313D1 (de) Colchinolderivate als gefässschädigende mittel
DE50102490D1 (de) Verwendung von substituierten imidazo [1,2-a]pyridin-, -pyrimidin- und -pyrazin-3-yl-amin-derivaten zur herstellung von medikamenten zur nos-inhibierung
DE69930739D1 (de) Transdermale verwendung von sekretin zur behandlung von autismus
MY143051A (en) Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
JP2005528323A (ja) 老化に関連した皮膚状態を治療する方法および局所処方物
BR0313694A (pt) Derivados de pirazol, composição medicinal contendo os mesmos, seu uso medicinal e intermediários para sua produção
BRPI0011640B8 (pt) ácidos aldônicos de oligossacarídeo e seu uso tópico
RU2003119460A (ru) Применение пэг-интерферона-а(пэг-inf-а) и рибавирина для лечения хронического гепатита с
ATE205494T1 (de) Pyridylfuran- und pyridylthiphenderivate und deren pharmazeutische verwendung
NO20065904L (no) Terapeutiske forbindelser
ATE374781T1 (de) Derivate von genkwanin und sakuranetin, deren kosmetische und therapeutische verwendung, und verfahren zu deren herstellung
BRPI0409427A (pt) composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
MX2013006163A (es) Compuestos y metodos para la reparación de la piel.
US20040147452A1 (en) Non-amphoteric glutathione derivative compositions for tropical application
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
US6174541B1 (en) Skin aging and wound treatment using cell migration agents
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
JP2004083432A (ja) エラスターゼ阻害剤
KR950008502A (ko) 3-또는4-클리코실옥시벤조피란 유도체 및 활성 성분으로서 이를 함유하는 알러지치료제
ATE253889T1 (de) Mittel und verfahren zur prävention und behandlung von immediaten überempfindlichkeitsreaktionen der haut

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties